FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2330902823> ?p ?o ?g. }

• W2330902823 endingPage "66" @default.
• W2330902823 startingPage "51" @default.
• W2330902823 abstract "Clinical Insights: Influenza Surveillance Global seroepidemiology: value and limitationsKaren L Laurie, Othmar G Engelhardt, John Wood & Maria D Van KerkhoveKaren L LaurieKaren L Laurie is an Immunologist and Virologist at the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne (Australia). Her research work is focused on the interplay between the immune response and the influenza virus. She utilizes the ferret model of immunization and influenza virus infection.Search for more papers by this author, Othmar G EngelhardtOthmar G Engelhardt is Principal Scientist in the Division of Virology of the National Institute for Biological Standards and Control, a center of the Medicines and Healthcare Products Regulatory Agency (London, UK). His interests include influenza serology, standardization and control of vaccines, and the improvement of candidate vaccine viruses.Search for more papers by this author, John WoodJohn Wood is a retired virologist from the National Institute for Biological Standards and Control (Ridge, UK). His work included testing of vaccine trial sera; preparation and distribution of influenza viruses and standard reagents; vaccine strain selection; and official batch-release testing of influenza vaccines.Search for more papers by this author & Maria D Van KerkhoveMaria D Van Kerkhove is an Epidemiologist at the Medical Research Council Centre for Outbreak Analysis and Modelling, Imperial College London (UK). She specialized in influenza, particularly avian and pandemic influenzas, and emerging respiratory pathogens. She received her PhD from the London School of Hygiene and Topical Medicine (UK).Search for more papers by this authorPublished Online:21 Jan 2014https://doi.org/10.2217/ebo.13.504AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail View chapterAbstract: Summary Serological studies can detect infection with influenza viruses in the absence of symptoms or positive virology, providing additional information on infection beyond estimates from epidemiological, clinical and virological data [1]. Although there are challenges to conducting serological studies for influenza and to standardize methodology and reporting [1,2], such studies provide useful data to inform decision making, including case definitions, severity and impact assessments and identification of populations with higher risks of infection. References1 Laurie KL , Huston P , Riley S et al. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting . Influenza Other Resp. Viruses 7 (2) , 211 – 224 (2013) . Crossref, Medline, Google Scholar2 Van Kerkhove MD , Broberg E , Engelhardt OG et al. The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy . Influenza Other Resp. Viruses 7 (3) , 231 – 234 (2013) . Crossref, Medline, Google Scholar3 Chen MI , Barr IG , Koh GCH et al. Serological response in RT-PCR confirmed H1N1-2009 influenza A by hemagglutination inhibition and virus neutralization assays: an observational study . PLoS ONE 5 , e12474 (2010) . Crossref, Medline, Google Scholar4 Miller E , Hoschler K , Hardelid P et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study . Lancet 375 , 1100 – 1108 (2010) . Crossref, Medline, Google Scholar5 Veguilla V , Hancock K , Schiffer J et al. Sensitivity and specificity of serologic assays for the detection of human infection with 2009 pandemic H1N1 virus in U.S. populations . J. Clin. Microbiol. 49 , 2210 – 2215 (2011) . Crossref, Medline, Google Scholar6 Iwasenko JM , Cretikos M , Paterson DL et al. Enhanced diagnosis of pandemic (H1N1) 2009 influenza infecton using molecular and serological testing in intensive care unit patients with suspected influenza . Clin. Infect. Dis. 51 , 70 – 72 (2010) . Crossref, Medline, Google Scholar7 Papenburg JBM , Hamelin ME , Rheaume C et al. Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory-confirmed secondary attack rates and evidence of asymptomatic infections . Clin. Infect. Dis. 51 , 1033 – 1041 (2010) . Crossref, Medline, Google Scholar8 Dormitzer PR , Galli G , Catellino F et al. Influenza vaccine immunology . Immunol. Rev. 239 , 167 – 177 (2011) . Crossref, Medline, CAS, Google Scholar9 Both GW , Sleigh MJ , Cox NJ , Kendal AP . Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites . J. Virol. 48 , 52 – 60 (1983) . Crossref, Medline, CAS, Google Scholar10 Caton AJ , Brownlee GG , Yewdell JW , Gerhard W . The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype) . Cell 31 , 417 – 427 (1982) . Crossref, Medline, CAS, Google Scholar11 Gerhard W , Yewdell J , Frankel ME , Webster R . Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies . Nature 290 , 713 – 717 (1981) . Crossref, Medline, CAS, Google Scholar12 Skehel JJ , Stevens DJ , Daniels RS et al. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody . Proc. Natl Acad. Sci. USA 81 , 1779 – 1873 (1984) . Crossref, Medline, CAS, Google Scholar13 Yewdell JW , Gerhard W . Antigenic characterization of viruses by monoclonal antibodies . Annu. Rev. Microbiol. 35 , 185 – 206 (1981) . Crossref, Medline, CAS, Google Scholar14 Martinez O , Tsibane T , Basler CF . Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery . Int. Rev. Immunol. 28 , 69 – 92 (2009) . Crossref, Medline, CAS, Google Scholar15 Ekiert DC , Bhabha G , Elsliger MA et al. Antibody recognition of a highly conserved influenza virus epitope: implications for universal prevention and therapy . Science 324 , 246 – 251 (2009) . Crossref, Medline, CAS, Google Scholar16 Sui JH , Perez S , Wei G et al. Structural and functional bases from broad-spectrum neutralization of avian and human influenza A viruses . Nat. Struct. Mol. Biol. 16 , 265 – 273 (2009) . Crossref, Medline, CAS, Google Scholar17 Julien JP , Lee PS , Wilson IA . Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA . Immunol. Rev. 250 , 180 – 198 (2012) . Crossref, Medline, Google Scholar18 Bodewes R , de Mutsert G , vander Klis FR et al. Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands . Clin. Vaccin. Immunol. 18 , 469 – 476 (2011) . Crossref, Medline, CAS, Google Scholar19 Hancock K , Veguilla V , Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus . N. Engl. J. Med. 361 , 1945 – 1952 (2009) . Crossref, Medline, CAS, Google Scholar20 Itoh Y , Shinya K , Kiso M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses . Nature 460 , 1021 – 1025 (2009) . Crossref, Medline, CAS, Google Scholar21 Katz JM , Hancock K , Veguilla V et al. Serum cross-reactive antibody response to a novel influenza A(H1N1) virus after vaccination with seasonal influenza vaccine . MMWR 58 , 521 – 524 (2009) . Medline, Google Scholar22 WHO, Global Influenza Surveillance Network. Manual for the Laboratory Diagnosis and Virological Surveillance of Influenza . WHO , Geneva, Switzerland (2011) . Google Scholar23 Salk JE . A simplified procedure for titrating hemagglutinating capacity of influenza-virus and the corresponding antibody . J. Immunol. 49 , 87 – 98 (1944) . Google Scholar24 Hirst GK . The agglutination of red cells by allantoic fluid of chick embryos infected with influenza virus . Science 94 , 22 – 23 (1941) . Crossref, Medline, CAS, Google Scholar25 Hirst GK . The quantitative determination of influenza virus and antibodies by means of red cell agglutination . J. Exp. Med. 75 , 47 – 64 (1942) . Crossref, Google Scholar26 Rowe T , Abernathy RA , Hu-Primmer J et al. Detection of antibody to avian Influenza A (H5N1) virus in human serum by using a combination of serologic assays . J. Clin. Microbiol. 37 , 937 – 943 (1999) . Crossref, Medline, CAS, Google Scholar27 Harmon MW , Rota PA , Walls HH , Kendal AP . Antibody responses in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection . J. Clin. Microbiol. 26 , 333 – 337 (1988) . Crossref, Medline, CAS, Google Scholar28 Tannock GA , Paul JA , Herd R et al. Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection . J. Clin. Microbiol. 27 , 524 – 528 (1989) . Crossref, Medline, CAS, Google Scholar29 WHO, Global Influenza Program. WHO Manual on Animal Influenza Diagnosis and Surveillance . WHO , Geneva, Switzerland (2002) . Google Scholar30 Clements ML , Betts RF , Tierney EL , Murphy BR . Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus . J. Clin. Microbiol. 24 , 157 – 160 (1986) . Crossref, Medline, CAS, Google Scholar31 Beutner KR , Chow T , Rubi E et al. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection . J. Infect. Dis. 140 , 844 – 850 (1979) . Crossref, Medline, CAS, Google Scholar32 Monto AS , Kendal AP . Effect of neuraminidase antibody on Hong Kong influenza . Lancet 1 , 623 – 625 (1973) . Crossref, Medline, CAS, Google Scholar33 Greenbaum JA , Kotturi MF , Kim Y et al. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population . Proc. Natl Acad. Sci. USA 106 , 20365 – 20370 (2009) . Crossref, Medline, CAS, Google Scholar34 Lambre CR , Terzidis H , Greffard AR , Webster RG . Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates . J. Immunol. Methods 135 , 49 – 57 (1990) . Crossref, Medline, CAS, Google Scholar35 Cate TR , Rayford Y , Nino D et al. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects . Vaccine 28 , 2076 – 2079 (2010) . Crossref, Medline, CAS, Google Scholar36 Meijer A , Bosman A , van de Kamp EE et al. Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test . J. Virol. Methods 132 , 113 – 120 (2006) . Crossref, Medline, CAS, Google Scholar37 Cox RJ , Madhun AS , Hauge S et al. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine . Vaccine 27 , 1889 – 1897 (2009) . Crossref, Medline, CAS, Google Scholar38 Couch RB , Decker WK , Utama B et al. Evaluations for in vitro correlates of immunogenicity of inactivated influenza A H5, H7 and H9 vaccines in humans . PLoS ONE 7 , e50830 (2012) . Crossref, Medline, CAS, Google Scholar39 Suarez DL . DIVA vaccination strategies for avian influenza virus . Avian Dis. 56 , 836 – 844 (2012) . Crossref, Medline, Google Scholar40 Fox JP , Cooney MK , Hall CE , Foy HM . Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness . Am. J. Epidemiol. 116 , 228 – 242 (1982) . Crossref, Medline, CAS, Google Scholar41 Hobson D , Curry RL , Beare AS , Ward-Gardner A . The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses . J. Hyg. (Lond.) 70 , 767 – 777 (1972) . Crossref, Medline, CAS, Google Scholar42 Potter CW , Oxford JS . Determinants of immunity to influenza infection in man . Br. Med. Bull. 35 , 69 – 75 (1979) . Crossref, Medline, CAS, Google Scholar43 Stephenson I , Das RG , Wood JM , Katz JM . Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study . Vaccine 25 , 4056 – 4063 (2007) . Crossref, Medline, CAS, Google Scholar44 Stephenson IHA , Major D , Newman RW et al. Reproducibility of serologic assays for influenza virus A(H5N1) . Emerg. Infect. Dis. 15 , 1250 – 1259 (2009) . Crossref, Google Scholar45 Wood JM , Major D , Heath A et al. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard . Vaccine 30 , 210 – 217 (2012 ) . Crossref, Medline, Google Scholar46 Koopmans M , Wilbrink B , Conyn M et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands . Lancet 363 , 587 – 593 (2004) . Crossref, Medline, Google Scholar47 Vong S , Ly S , Van Kerkhove MD et al. Risk factors associated with subclinical human infection with avian Influenza A (H5N1) virus- Cambodia, 2006 . J. Infect. Dis. 199 , 1744 – 1752 (2009) . Crossref, Medline, Google Scholar48 Apisarnthanarak A , Erb S , Stephenson I et al. Seroprevalence of Anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center . Clin. Infect. Dis. 40 , e16 – e18 (2005) . Crossref, Medline, Google Scholar49 Bai T , Zhou J , Shu Y . Serologic study for Influenza A (H7N9) among high-risk groups in China . N. Engl. J. Med. 368 , 2339 – 2340 (2013) . Crossref, Medline, CAS, Google Scholar50 Nicoll A , Ammon A , Amato Gauci A et al. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe . Public Health 124 , 14 – 23 (2010) . Crossref, Medline, CAS, Google Scholar51 Van Kerkhove MD , Asikainen T , Becker NG et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling . PLoS Med. 7 , e1000275 (2010) . Crossref, Medline, Google Scholar52 Briand S , Mounts AW , Chamberland M . Challenges of global surveillance during an influenza pandemic . Public Health 125 , 247 – 256 (2011) . Crossref, Medline, CAS, Google Scholar53 Broberg E , Nicoll A , Amato-Gauci A . Seroprevalence to influenza A(H1N1) 2009 virus - where are we? Clin. Vaccine Immunol. 18 (8) , 1205 – 1212 (2011) . Crossref, Medline, CAS, Google Scholar54 Kelly H , Peck HA , Laurie KL et al. The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countires prior to vaccination . PLoS ONE 6 , e21828 (2011) . Crossref, Medline, CAS, Google Scholar55 Van Kerkhove MD , Hirve S , Koukounari A , Mounts AW ; H1N1pdm serology working group. Estimating age-specific infection rates for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries . Influenza Other Resp. Viruses 7 (5) , 872 – 886 (2013) . Crossref, Medline, Google Scholar56 Van Kerkhove MD , Mumford E , Mounts AW et al. Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review . PLoS ONE 6 , E14582 (2011) . Crossref, Medline, CAS, Google Scholar57 WHO. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus . Weekly Epidemiol. Record. 24 , 229 – 236 (2010) . Google Scholar58 Van Kerkhove MD , Riley S , Lipsitch M et al. Comment on ‘seroevidence for H5N1 influenza infections in humans: meta-analysis‘ . Science 336 , 1506 (2012) . Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByCONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement9 August 2016 | Influenza and Other Respiratory Viruses, Vol. 11, No. 1International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEClinical and Vaccine Immunology, Vol. 22, No. 8 Clinical Insights: Influenza SurveillanceMetrics Downloaded 7 times History Published online 21 January 2014 Published in print January 2014 Information© Future Medicine Ltd© Future Medicine LtdPDF download" @default.
• W2330902823 created "2016-06-24" @default.
• W2330902823 creator A5023324131 @default.
• W2330902823 creator A5039638832 @default.
• W2330902823 creator A5079615051 @default.
• W2330902823 creator A5080592111 @default.
• W2330902823 date "2014-01-01" @default.
• W2330902823 modified "2023-10-03" @default.
• W2330902823 title "Global seroepidemiology: value and limitations" @default.
• W2330902823 cites W1591601971 @default.
• W2330902823 cites W1618733816 @default.
• W2330902823 cites W1655902188 @default.
• W2330902823 cites W1742336838 @default.
• W2330902823 cites W1808739935 @default.
• W2330902823 cites W1824220324 @default.
• W2330902823 cites W1896461377 @default.
• W2330902823 cites W1965540493 @default.
• W2330902823 cites W1971279413 @default.
• W2330902823 cites W1972620148 @default.
• W2330902823 cites W1972767822 @default.
• W2330902823 cites W1980177337 @default.
• W2330902823 cites W1986315221 @default.
• W2330902823 cites W1987669718 @default.
• W2330902823 cites W1999899046 @default.
• W2330902823 cites W2004477764 @default.
• W2330902823 cites W2019907079 @default.
• W2330902823 cites W2021481766 @default.
• W2330902823 cites W2041531847 @default.
• W2330902823 cites W2045870263 @default.
• W2330902823 cites W2050306167 @default.
• W2330902823 cites W2055582636 @default.
• W2330902823 cites W2060770352 @default.
• W2330902823 cites W2062740562 @default.
• W2330902823 cites W2068592034 @default.
• W2330902823 cites W2070215035 @default.
• W2330902823 cites W2071851819 @default.
• W2330902823 cites W2076410390 @default.
• W2330902823 cites W2077753444 @default.
• W2330902823 cites W2085474794 @default.
• W2330902823 cites W2086472794 @default.
• W2330902823 cites W2091238642 @default.
• W2330902823 cites W2097022764 @default.
• W2330902823 cites W2098349861 @default.
• W2330902823 cites W2102197319 @default.
• W2330902823 cites W2105789365 @default.
• W2330902823 cites W2107587363 @default.
• W2330902823 cites W2112934045 @default.
• W2330902823 cites W2117278984 @default.
• W2330902823 cites W2122298249 @default.
• W2330902823 cites W2122385379 @default.
• W2330902823 cites W2135851703 @default.
• W2330902823 cites W2135944269 @default.
• W2330902823 cites W2137820930 @default.
• W2330902823 cites W2148828011 @default.
• W2330902823 cites W2152617913 @default.
• W2330902823 cites W2153570511 @default.
• W2330902823 cites W2155467153 @default.
• W2330902823 cites W2156643271 @default.
• W2330902823 cites W2160885155 @default.
• W2330902823 cites W2164807254 @default.
• W2330902823 cites W2169180983 @default.
• W2330902823 cites W2339080478 @default.
• W2330902823 doi "https://doi.org/10.2217/ebo.13.504" @default.
• W2330902823 hasPublicationYear "2014" @default.
• W2330902823 type Work @default.
• W2330902823 sameAs 2330902823 @default.
• W2330902823 citedByCount "2" @default.
• W2330902823 countsByYear W23309028232015 @default.
• W2330902823 countsByYear W23309028232016 @default.
• W2330902823 crossrefType "other" @default.
• W2330902823 hasAuthorship W2330902823A5023324131 @default.
• W2330902823 hasAuthorship W2330902823A5039638832 @default.
• W2330902823 hasAuthorship W2330902823A5079615051 @default.
• W2330902823 hasAuthorship W2330902823A5080592111 @default.
• W2330902823 hasConcept C105795698 @default.
• W2330902823 hasConcept C2776291640 @default.
• W2330902823 hasConcept C33923547 @default.
• W2330902823 hasConceptScore W2330902823C105795698 @default.
• W2330902823 hasConceptScore W2330902823C2776291640 @default.
• W2330902823 hasConceptScore W2330902823C33923547 @default.
• W2330902823 hasLocation W23309028231 @default.
• W2330902823 hasOpenAccess W2330902823 @default.
• W2330902823 hasPrimaryLocation W23309028231 @default.
• W2330902823 hasRelatedWork W1967500081 @default.
• W2330902823 hasRelatedWork W2049150502 @default.
• W2330902823 hasRelatedWork W2172599225 @default.
• W2330902823 hasRelatedWork W2176627345 @default.
• W2330902823 hasRelatedWork W2365537987 @default.
• W2330902823 hasRelatedWork W2365751862 @default.
• W2330902823 hasRelatedWork W2373948225 @default.
• W2330902823 hasRelatedWork W2379531677 @default.
• W2330902823 hasRelatedWork W2945191958 @default.
• W2330902823 hasRelatedWork W4285411252 @default.
• W2330902823 isParatext "false" @default.
• W2330902823 isRetracted "false" @default.
• W2330902823 magId "2330902823" @default.
• W2330902823 workType "other" @default.